Trials / Conditions / Recurrent Respiratory Papillomatosis

Recurrent Respiratory Papillomatosis

23 registered clinical trials studyying Recurrent Respiratory Papillomatosis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients NCT07317154	Mayo Clinic	Phase 1
Recruiting	Merck IIT: RRP Pembro and Lenvatinib NCT04645602	Yale University	EARLY_Phase 1
Recruiting	Zopa Retreatment and Vector Shedding in Adults With RRP NCT06538480	Precigen, Inc	Phase 4
Recruiting	The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) NCT06412172	Massachusetts General Hospital	—
Active Not Recruiting	Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis NCT04724980	Precigen, Inc	Phase 1 / Phase 2
Completed	M7824 in People With Recurrent Respiratory Papillomatosis NCT03707587	National Cancer Institute (NCI)	Phase 2
Unknown	Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) NCT03465280	Newcastle-upon-Tyne Hospitals NHS Trust	—
Unknown	Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) NCT02854761	Efranat Ltd.	Phase 1
Completed	Avelumab for People With Recurrent Respiratory Papillomatosis NCT02859454	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients NCT02632344	Massachusetts General Hospital	Phase 2
Unknown	Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis NCT02555800	Centro de Investigación en. Enfermedades Infecciosas, Mexico	Phase 2
Completed	Recurrent Respiratory Papillomatosis and Extraesophageal Reflux NCT02592902	University Hospital Ostrava	N/A
Unknown	4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children NCT01995721	National Institute of Child Health, Hungary	Phase 3
Completed	Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesio NCT02217358	University Hospital Ostrava	N/A
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
Withdrawn	Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis NCT01058317	Massachusetts Eye and Ear Infirmary	Phase 2 / Phase 3
Completed	Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) NCT01020747	Massachusetts General Hospital	Phase 1
Withdrawn	Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis NCT00829608	University of Missouri-Columbia	EARLY_Phase 1
Terminated	Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") NCT00747461	CSA Medical, Inc.	Phase 4
Completed	Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis NCT00571701	Northwell Health	Phase 2
Completed	Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP NCT00550914	Massachusetts Eye and Ear Infirmary	—
Completed	A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis NCT00038714	Nventa Biopharmaceuticals Corporation	Phase 2
Completed	Use of Cidofovir for Recurrent Respiratory Papillomatosis NCT00205374	University of Wisconsin, Madison	Phase 4